Influence of Disease-Modifying Therapy on the Efficacy of Vutrisiran in Transthyretin Cardiac Amyloidosis.

Abovich A, Fontana M, Claggett B, Gillmore JD, Cappelli F, Ambardekar AV, Morbach C, Garcia-Pavia P, Witteles RM, Maurer MS, Jay PY, Kosheleff A, Bansilal S, Solomon SD.

Open source

DOI: 10.1016/j.jacc.2026.07.023
Published: 2026-08-05
Container: J Am Coll Cardiol
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jacc.2026.07.023,
  title = {Influence of Disease-Modifying Therapy on the Efficacy of Vutrisiran in Transthyretin Cardiac Amyloidosis.},
  author = {Abovich A and  Fontana M and  Claggett B and  Gillmore JD and  Cappelli F and  Ambardekar AV and  Morbach C and  Garcia-Pavia P and  Witteles RM and  Maurer MS and  Jay PY and  Kosheleff A and  Bansilal S and  Solomon SD.},
  year = {2026},
  journal = {J Am Coll Cardiol},
  doi = {10.1016/j.jacc.2026.07.023},
  url = {https://doi.org/10.1016/j.jacc.2026.07.023}
}

RIS

TY  - JOUR
TI  - Influence of Disease-Modifying Therapy on the Efficacy of Vutrisiran in Transthyretin Cardiac Amyloidosis.
AU  - Abovich A
AU  -  Fontana M
AU  -  Claggett B
AU  -  Gillmore JD
AU  -  Cappelli F
AU  -  Ambardekar AV
AU  -  Morbach C
AU  -  Garcia-Pavia P
AU  -  Witteles RM
AU  -  Maurer MS
AU  -  Jay PY
AU  -  Kosheleff A
AU  -  Bansilal S
AU  -  Solomon SD.
PY  - 2026
JO  - J Am Coll Cardiol
DO  - 10.1016/j.jacc.2026.07.023
UR  - https://doi.org/10.1016/j.jacc.2026.07.023
ER  -

APA

A, A., M, F., B, C., JD, G., F, C., AV, A., C, M., P, G., RM, W., MS, M., PY, J., A, K., S, B., & SD., S. (2026). Influence of Disease-Modifying Therapy on the Efficacy of Vutrisiran in Transthyretin Cardiac Amyloidosis.. J Am Coll Cardiol. https://doi.org/10.1016/j.jacc.2026.07.023

Source records

europe-pmc · retrieved 2026-09-25T07:06:19.574Z